ICU sedation, delirium & recovery

The association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors

J Crit CarePublished Retrospective cohort study

Main finding · Mental health problems (composite)Result — go to the resultAdjusted odds ratio 0.46 95% CI 0.22–0.93

Authors' conclusion

Exposure to IL-6 inhibitors as treatment for critically ill COVID-19 patients was associated with a lower prevalence of mental health problems, primarily driven by a lower prevalence of PTSD symptoms, one year after ICU admission.

Study context

Population
Adult ICU survivors admitted for COVID-19 (Sept 2020–Mar 2022) with one-year follow-up, two university medical centres in the Netherlandsprimary analysis
Participants
170 survivors
Exposure
IL-6 inhibitor exposure vs no exposure
  • Exposedn = 119
  • Unexposedn = 51reference
Outcome
Composite of:
  • Post-traumatic stress disorder (PTSD)
  • Anxiety
  • Depression symptoms (IES-6 or IES-R; Hospital Anxiety and Depression Scale (HADS))
Follow-up
One year after ICU admission
Methodological detailsprospectively collected outcome data, multicentre
  • Prospectively collected outcome data
  • Multicentre

Main finding

Mental health problems (composite)

Adjusted odds ratio

0.46

95% CI 0.22–0.93

Exposed vs Unexposed
aOR 0.46 (95% CI 0.22–0.93)

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeaOR (95% CI)
PTSD symptoms alone · 1 year after ICU admission0.45 (0.20–0.97)

Anxiety symptoms alone · 1 year after ICU admission

No significant association with IL-6 inhibitor exposure (aOR 0.77, 95% CI 0.34-1.72)

Depression symptoms alone · 1 year after ICU admission

No significant association with IL-6 inhibitor exposure (aOR 0.71, 95% CI 0.33-1.50)

Original publication

The association between interleukin-6 inhibitors as treatment for COVID-19 and mental health problems in ICU survivors. J Crit Care. Published 9 April 2026. doi:10.1016/j.jcrc.2026.155558

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.